Topiramate
Product Images NDC 68387-560

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 68387-560). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Keltman Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image For 100mg (Topiramate 100mg Label)

Label for Topiramate 100 mg tablets by Keltman Pharmaceuticals Inc. The label indicates it is a generic Topamax formulation supplied in a package containing 30 tablets. Each tablet contains 100 mg of topiramate. Instructions include dispensing with a medication guide, storage at 20-25°C, and keeping out of reach of children. Manufacturer details and lot/expiration information are also shown.*

FDA Label Image

Label Image For 200mg (Topiramate 200mg Label)

Topiramate 200mg tablet bottle label by Keltman Pharmaceuticals Inc. The label shows 90 tablets per bottle, each containing 200mg Topiramate. It includes lot number 0077791 with expiration date 6/2012. Storage and usage instructions are noted, along with manufacturer Invagen Pharmaceuticals Inc. and distributor Keltman Pharmaceuticals information. Federal caution and FDA reporting details are also present.*

FDA Label Image

Label Image For 25mg (Topiramate 25mg Label)

Topiramate 25 mg tablets label from Keltman Pharmaceuticals Inc. The label indicates the product contains 90 tablets with each tablet containing 25 mg of topiramate. It includes details like lot number 907519 1, expiration date 7/2011, and manufacturing information by Invagen Pharmaceuticals Inc. Directions to take tablets and storage instructions are also present along with barcode and FDA side effect reporting information.*

FDA Label Image

Figure 2 (Topiramate Fig)

A Kaplan-Meier curve showing the cumulative rate of time to first seizure over a 500-day period for Topiramate at 50 mg/day and 400 mg/day doses. The graph compares seizure occurrence rates at the two dosages, with a p-value of 0.0002 indicating statistical significance.*

FDA Label Image

Figure 3 (Topiramate Fig1)

Topiramate round tablets in four strengths: 25 mg white tablets, 50 mg yellow tablets, 100 mg light blue tablets, and 200 mg pink tablets. Each tablet strength is shown inside a circle with the imprint 'IG'. Manufactured by Keltman Pharmaceuticals Inc.*

FDA Label Image

Figure 1 (Topiramate Str)

Chemical structure of topiramate showing its molecular arrangement with multiple rings, oxygen atoms, and sulfonamide groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.